Pfizer chasing AstraZeneca in potential $100 billion-plus deal

By | 28/04/2014

LONDON (Reuters) – U.S. drugmaker Pfizer wants to buy AstraZeneca in a deal that could value its smaller British rival at more than $100 billion, creating a new giant on the global pharmaceuticals scene.

Link to article:

Category: Business Tags:

About PentaBytes

PentaBytes is a Blog or Digital Magazine with direct link for the best selected news in real time. The last news about Technology, Economy, Business, Startups, Society, Travel, etc. Interviews and interesting articles. You can contact with us in the contact page. Thanks.

Leave a Reply

Your email address will not be published. Required fields are marked *